logo
14:24 Feb 25

Senores Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
773.45
-5.80 (-0.74%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Senores Pharmaceuticals Ltd. Financials

Senores Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
773.45
-5.80 (-0.74%)
14:24 Feb 25
Quality
image/svg+xml

59/100
High Financial Strength

Valuation
image/svg+xml

32/100
Mid Valuation

Technical

46/100
Technically Neutral

Strength

10

Weakness

6

Opportunity

0

Threats

0

7.44 %

ROE %

4.77 %

ROA %

22.06

EPS

170.73

BVPS

14.70 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
14.17 35.34 214.52 398.25
Operating Expenses +
12.23 22.66 172.93 308.55
Raw Material
10.43 13.24 102.26 181.46
Increase Decrease in Cost
-2.4 -0.48 3.88 -0.76
Other Manufacturing Expense
0 0 0 0
Employee Cost
2.86 4.79 35.46 60.37
Miscellaneous Expenses
22.2 30.91 171.93 247.12
Operating Profit
1.94 12.68 41.59 89.7
Other Income
0.46 3.68 2.82 19.26
Depreciation
0.7 1.78 10.02 16.84
Interest
0.56 2.14 9.45 21.55
Profit before tax and exceptio..
1.14 12.44 24.94 70.57
Exceptional Items
0 0 0 0
PBT
1.14 12.44 24.94 70.57
Provision for Taxation
0.15 4 -7.76 12.23
Net Profit
0.99 8.43 32.71 58.34
NET Profit after MI
0.99 8.43 31.46 58.56
EPS
1.81 8.87 12.21 16.12
Operating Profit Margin (%)
13.69 35.88 19.39 22.52
Net Profit Margin (%)
6.99 23.85 14.67 14.7

Senores Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 45.80 45.80 45.80 45.80 45.80
FII 3.40 4.30 3.70 4.20 4.20
Public 9.30 8.60 9.50 9.60 11.80
Others 41.50 41.30 41.00 40.40 38.20
Shareholder Shares Holding %
Research 360 logo
Download Our App On: